Predictive Oncology Inc.

POAI

NASDAQ

Technology

Software - Infrastructure

Pittsburgh, PA, US23 employeesaxecompute.com

$4.20

+0.64(17.98%)

Mkt Cap $3M

$1.41

$18.00

52-Week Range

At a Glance

AI-generated

Net loss expanded dramatically to -$233.1M from -$12.7M, reflecting a -1740.6% YoY change driven by non-cash fair value declines in the new ATH digital asset treasury strategy amid the pivot to GPU compute services, with operating losses expected to persist during scaling.

Revenue breakdown: Drug Discovery Services Segment (100%).

8-K

Axe Compute Inc. appointed Kyle Okamoto as President with a $360,000 base salary and 300,000 stock options, while announcing $12 million in executed agreements projected to generate $835,000 in monthly income.

$3M

Market Cap

$3M

Revenue

-$400M

Net Income

Employees23

Fundamentals

How The Business Makes Money

Revenue by Segment

Drug Discovery Services Segment100%($210.1K)

Activity

What Changed Recently

Management Change

Mar 31, 2026

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** Appointme

Management Change

Mar 8, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment o

Management Change

Feb 8, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Termination o

Management Change

Jan 21, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 15

Financial Results

Mar 30, 2026

. Results of Operations and Financial Condition.** On March 31, 2026, Axe Compute Inc. (the “Company”) issued a press release announcing its financial results f

Peer Companies

Company	Price	Change	Market Cap	P/E
CYCNCyclerion Therapeutics, I...	$6.21	-2.66%	$24M	-2.3
VYNEVYNE Therapeutics Inc.	$0.61	+0.58%	$10M	-1.0
TCRTAlaunos Therapeutics, Inc...	$2.93	-0.68%	$7M	-1.7
KTTAPasithea Therapeutics Cor...	$0.77	+3.49%	$6M	-0.4
HSCSHeartSciences Inc.	$2.30	-2.54%	$5M	-0.9
BNGOBionano Genomics, Inc.	$1.19	+0.00%	$4M	-0.2
MYNZMainz Biomed B.V.	$0.70	-5.07%	$3M	-0.0
AIMAIM ImmunoTech Inc.	$0.60	+9.05%	$2M	—

Analyst View

Company Profile

CIK0001446159

ISINUS74039M4087

CUSIP74039M408

Phone412 432 1500

Address91 43rd Street, Pittsburgh, PA, 15201, US

SEC EDGAR